The T-cell-mediated resolution of herpes simplex virus type 2 (HSV-2) genital infections is not fully understood. In these studies, the mechanisms by which CD8 ؉ T cells clear virus from the genital epithelium were examined. Ovalbumin (OVA)-specific CD8 ؉ T cells from OT-I transgenic mice cleared a thymidine kinase-deficient, ovalbumin-expressing HSV-2 virus (HSV-2 tk ؊ OVA) from the genital epithelium of recipient mice, and clearance was abrogated by in vivo neutralization of gamma interferon (IFN-␥). Further, CD8؉ OT-I T cells deficient in IFN-␥ were unable to clear HSV-2 tk ؊ OVA from the vaginal epithelium. The requirement for cytolytic mechanisms in HSV-2 tk ؊ OVA clearance was tested in radiation chimeras by adoptive transfer of wild-type or perforin-deficient OT-I T cells to irradiated Fas-defective or wild-type recipients. Although a dramatic decrease in viral load was observed early after challenge with HSV-2 tk ؊ OVA, full resolution of the infection was not achieved in recipients lacking both perforin-and Fas-mediated cytolytic pathways. These results suggest that IFN-␥ was responsible for an early rapid decrease in HSV-2 virus titer. However, either perforin-or Fas-mediated cytolytic mechanisms were required to achieve complete clearance of HSV-2 from the genital epithelium.Herpes simplex virus type 2 (HSV-2) infects epithelial cells in the genital mucosa, spreads to the sensory ganglia via retrograde transport, and establishes a lifelong latent infection in sensory neurons (50). The virus periodically reactivates and descends sensory neurons via anterograde transport, resulting in development of recurrent lesions at or near the site of primary infection or in shedding of infectious virus in the absence of disease symptoms. The primary and recurrent lesions of immunocompetent individuals are generally self limiting and are resolved primarily by cell-mediated immune mechanisms. Recurrent disease is less well controlled in immunocompromised individuals, resulting in more frequent recurrences and sometimes severe mucocutaneous disease manifestations. Studies of HSV infection in human immunodeficiency virus (HIV)-infected individuals suggested that the severity of HSV disease could be inversely correlated with the number of HSV-specific CD8 ϩ T cells (39). Studies of recurrent HSV lesions in immunocompetent humans have demonstrated the early infiltration of CD4 ϩ T cells and macrophages, local production of IFN-␥, and late arrival of CD8ϩ T cells at the site of HSV infection. Both CD4 ϩ and CD8 ϩ T lymphocytes capable of IFN-␥ secretion and HSVspecific cytolysis have been isolated from human herpetic lesions (10) and clearance of infectious virus, and resolution of lesions has been correlated with the detection of HSV-specific cytolytic T-lymphocyte activity (10, 22-23). However, the role for these cytolytic and noncytolytic immune mechanisms in resolution of HSV-2 genital infections is not well understood.Murine models of HSV-2 genital infection have also demonstrated the importance of cell-mediated imm...